BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB, ABBVIE, ASTRAZENECA AND PFIZER

Another Round of Big Pharma Giants Beat Wall Street Expectations In Q1 After Hiking Prices Throughout Pandemic

Big Pharma giants Bristol-Myers Squibb, Pfizer, AbbVie and AstraZeneca all held earnings calls within the past week that beat Wall Street analysts’ expectations. The brand name drug companies’ strong earnings came after the companies launched several rounds of price hikes during the COVID-19 pandemic and as the pharmaceutical industry continues to wage a campaign to keep drug prices high. All four Big Pharma giants also share a history of engaging in anti-competitive tactics that limit competition and prevent patients from accessing more affordable alternatives to their branded products.

Bristol-Myers Squibb

Pfizer

AbbVie

AstraZeneca

The blockbuster earnings come as all four Big Pharma companies have continued to hike prices on their prescription drugs during the pandemic, despite a growing crisis of affordability, and engage in questionable behavior.

Bristol-Myers Squibb

Pfizer

AbbVie

AstraZeneca

AstraZeneca has a long history of hiking prices on Americans struggling to afford their medications:

Read more on first quarter earnings from Big Pharma giant Johnson & Johnson HERE.

Read more on Q1 earnings from Novartis, GlaxoSmithKline, Amgen, and Roche HERE.

Read more on earnings from the first quarter of the year from Sanofi, Merck and Eli Lilly HERE.

Learn more about solutions to lower prescription drug prices and hold Big Pharma accountable HERE.

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.